About CareFusion (NYSE:CFN)
CareFusion Corporation is a global medical technology company. The Company operates in two business segments: Medical Systems and Procedural Solutions. The Company's primary product brands include: Alaris intravenous (IV) infusion systems; Pyxis and Rowa automated medication dispensing and supply management systems; AVEA, Vela and LTV Series respiratory ventilators; ChloraPrep skin antiseptic products; MaxGuard, MaxPlus, MaxZero, SmartSite and Texium needle-free IV infusion valves, administration sets and accessories; V. Mueller and Snowden-Pencer open surgical and laparoscopic instrumentation; PleurX, Achieve and Temno interventional specialty products; AirLife disposable ventilator circuits and oxygen masks used for providing respiratory therapy; Vital Signs single-use consumables for respiratory care and anesthesiology; Jaeger and SensorMedics cardiopulmonary diagnostic equipment, and MedMined data mining surveillance software and analytics.
Industry, Sector and Symbol
Sub-IndustryHealth Care Equipment
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
EPS (Most Recent Fiscal Year)N/A
Return on Equity12.80%
Return on Assets7.62%
CareFusion (NYSE:CFN) Frequently Asked Questions
What is CareFusion's stock symbol?
CareFusion trades on the New York Stock Exchange (NYSE) under the ticker symbol "CFN."
How were CareFusion's earnings last quarter?
CareFusion Co. (NYSE:CFN) posted its quarterly earnings data on Thursday, February, 5th. The healthcare company reported $0.99 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.79 by $0.20. The healthcare company had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.01 billion. CareFusion had a net margin of 16.18% and a return on equity of 12.80%. The firm's revenue was up 15.9% compared to the same quarter last year. During the same quarter last year, the firm posted $0.54 earnings per share. View CareFusion's Earnings History.
Who are some of CareFusion's key competitors?
Some companies that are related to CareFusion include Telefônica Brasil (VIV), Consolidated Edison (ED), C R Bard (BCR), PG&E (PCG), Wipro (WIT), Twitter (TWTR), Stanley Black & Decker (SWK), Sprint (S), Corning (GLW), Ferrari (RACE), Aptiv (APTV), Sasol (SSL), Parker Hannifin (PH), Rogers Communications (RCI), Continental Resources (CLR), Kraft Heinz Foods (HNZ), RELX (RELX) and AvalonBay Communities (AVB).
Has CareFusion been receiving favorable news coverage?
Media stories about CFN stock have trended somewhat positive on Thursday, according to Accern Sentiment. The research group identifies negative and positive news coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. CareFusion earned a coverage optimism score of 0.23 on Accern's scale. They also assigned news stories about the healthcare company an impact score of 46.10 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.
What is CareFusion's stock price today?
One share of CFN stock can currently be purchased for approximately $59.94.
How big of a company is CareFusion?
CareFusion has a market capitalization of $12.24 billion.
How can I contact CareFusion?
CareFusion's mailing address is 3750 Torrey View Ct, SAN DIEGO, CA 92130-2622, United States. The healthcare company can be reached via phone at +1-800-6848880.
MarketBeat Community Rating for CareFusion (CFN)MarketBeat's community ratings are surveys of what our community members think about CareFusion and other stocks. Vote "Outperform" if you believe CFN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CFN will underperform the S&P 500 over the long term. You may vote once every thirty days.
CareFusion (NYSE:CFN) Analyst Ratings History
(Data available from 4/19/2016 forward)
|Date||Brokerage||Action||Rating||Price Target||Impact on Share Price||Details|
CareFusion (NYSE:CFN) Earnings History and Estimates Chart
CareFusion (NYSE CFN) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|2/5/2015||Q215||$0.79||$0.99||$1.0116 billion||$1.07 billion||View||N/A|
|11/6/2014||Q115||$0.49||$0.50||$920.50 million||$922.00 million||View||N/A|
|8/7/2014||Q414||$0.72||$0.79||$1.04 billion||$1.1220 billion||View||Listen|
|5/5/2014||Q314||$0.62||$0.60||$986.67 million||$968.00 million||View||Listen|
|2/3/2014||Q214||$0.54||$0.54||$911.13 million||$922.00 million||View||Listen|
|11/7/2013||Q1 2014||$0.40||$0.44||$817.82 million||$830.00 million||View||N/A|
|8/8/2013||Q4 2013||$0.56||$0.55||$918.25 million||$903.00 million||View||Listen|
|5/9/2013||Q3 2013||$0.53||$0.59||$909.16 million||$901.00 million||View||Listen|
CareFusion (NYSE:CFN) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
CareFusion (NYSE CFN) Insider Trading and Institutional Ownership History
CareFusion (NYSE CFN) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|2/6/2015||Jonathan Wygant||CAO||Sell||1,700||$59.79||$101,643.00|| |
|2/6/2015||Philip L Francis||Director||Sell||40,980||$59.89||$2,454,292.20|| |
|12/15/2014||Thomas J Leonard||Insider||Sell||25,000||$58.87||$1,471,750.00|| |
|12/4/2014||Donald Abbey||EVP||Sell||1,000||$59.35||$59,350.00|| |
|11/12/2014||J Michael Losh||Director||Sell||12,630||$57.32||$723,951.60|| |
|10/6/2014||James F Hinrichs||CFO||Sell||20,000||$56.91||$1,138,200.00|| |
|10/6/2014||Thomas J Leonard||Insider||Sell||8,400||$57.16||$480,144.00|| |
|10/1/2014||James F Hinrichs||CFO||Sell||20,000||$45.07||$901,400.00|| |
|9/19/2014||Thomas J Leonard||Insider||Sell||16,600||$47.01||$780,366.00|| |
|9/15/2014||Thomas J Leonard||Insider||Sell||25,000||$46.17||$1,154,250.00|| |
|7/7/2014||Thomas J Leonard||Insider||Sell||1,250||$45.47||$56,837.50|| |
|7/1/2014||Thomas J Leonard||Insider||Sell||19,721||$45.00||$887,445.00|| |
|6/6/2014||James F Hinrichs||CFO||Sell||21,506||$44.07||$947,769.42|| |
|6/2/2014||Thomas J Leonard||Insider||Sell||1,250||$42.81||$53,512.50|| |
|5/29/2014||Fortune Gordon La||EVP||Sell||2,158||$42.61||$91,952.38|| |
|5/20/2014||Kieran Gallahue||CEO||Sell||100,000||$42.98||$4,298,000.00||305,122|| |
|5/19/2014||Fortune Gordon La||EVP||Sell||38,738||$42.70||$1,654,112.60||20,894|| |
|5/19/2014||Thomas Leonard||Insider||Sell||30,000||$42.89||$1,286,700.00||34,553|| |
|5/5/2014||Thomas Leonard||Insider||Sell||1,250||$39.06||$48,825.00||34,553|| |
|4/7/2014||Thomas Leonard||Insider||Sell||1,250||$40.05||$50,062.50||35,803|| |
|4/4/2014||Donald Abbey||EVP||Sell||10,076||$41.79||$421,076.04||28,143|| |
|3/3/2014||Thomas Leonard||Insider||Sell||1,250||$40.26||$50,325.00||37,053|| |
|2/5/2014||Philip Francis||Director||Buy||6,500||$38.61||$250,965.00||4,515|| |
|2/5/2014||Thomas Leonard||Insider||Sell||21,496||$38.24||$822,007.04||38,303|| |
|1/9/2014||Kieran Gallahue||CEO||Sell||25,000||$41.05||$1,026,250.00||122,873|| |
|1/6/2014||Thomas Leonard||Insider||Sell||1,250||$39.48||$49,350.00||59,799|| |
|12/2/2013||James Hinrichs||CFO||Sell||28,078||$40.13||$1,126,770.14||27,024|| |
|12/2/2013||Kieran Gallahue||CEO||Sell||25,000||$40.09||$1,002,250.00||147,873|| |
|12/2/2013||Thomas Leonard||Insider||Sell||1,250||$39.99||$49,987.50||61,049|| |
|11/4/2013||Thomas J Leonard||Insider||Sell||1,250||$39.06||$48,825.00|| |
|10/1/2013||Thomas J Leonard||Insider||Sell||1,250||$36.99||$46,237.50|| |
|9/9/2013||Fortune Gordon La||EVP||Sell||33,960||$36.55||$1,241,238.00|| |
|9/3/2013||Thomas Leonard||Insider||Sell||1,250||$35.70||$44,625.00||64,799|| |
|8/26/2013||J Michael Losh||Director||Sell||53,311||$35.67||$1,901,603.37||32,858|| |
CareFusion (NYSE CFN) News Headlines
CareFusion (NYSE:CFN) SEC Filings
This page is loading this company's SEC Filings. Please wait...
CareFusion (NYSE:CFN) Income Statement, Balance Sheet and Cash Flow Statement
CareFusion (NYSE CFN) Stock Chart for Thursday, April, 19, 2018